YGION Biomedical

YGION Biomedical GmbH develops individualized neoantigen-based cancer vaccines. Their YGNITE™ technology platform identifies, produces, and targets the delivery of relevant peptide neoepitopes to activate the patient's immune system. This results in safe, potent, and precise targeted cancer treatment.

Funding Round: Series A

Funding Amount: €15M

Date: 21-May-2024

Investors: An Austrian private trust

Markets: Biotechnology, Oncology, Immunotherapy

HQ: Vienna, Vienna, Austria

Founded: 2022

Website: http://www.ybion.bio/

LinkedIn: https://www.linkedin.com/company/ygion-biomedical/

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/ygion-biomedical?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook:


Similar Startups


Leave a Comment

    🔷 Buy VC Database 🟩 Buy Startup Database 🎁 Get Free Sample

    Share this: